Elanco宣布Trucan™ Ultra Lyme-L4获美国农业部批准，成为首款且唯一一款用于犬类的莱姆病与钩端螺旋体病0.5毫升联合疫苗

美股速递06-15

Elanco Animal Health Inc宣布，其研发的Trucan™ Ultra Lyme-L4疫苗已获得美国农业部（USDA）的正式批准。该产品是全球首个且目前唯一一款针对犬类莱姆病和钩端螺旋体病的0.5毫升联合疫苗，标志着动物疫苗领域的一项重要突破。这一进展有望为宠物犬提供更便捷、高效的疾病防护方案。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1140079176?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-06-15 20:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1140079176","market":"us","top_or_hot":-1,"title":"Elanco宣布Trucan™ Ultra Lyme-L4获美国农业部批准，成为首款且唯一一款用于犬类的莱姆病与钩端螺旋体病0.5毫升联合疫苗","media":"美股速递","content":"<p>Elanco Animal Health Inc宣布，其研发的Trucan™ Ultra Lyme-L4疫苗已获得美国农业部（USDA）的正式批准。该产品是全球首个且目前唯一一款针对犬类莱姆病和钩端螺旋体病的0.5毫升联合疫苗，标志着动物疫苗领域的一项重要突破。这一进展有望为宠物犬提供更便捷、高效的疾病防护方案。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elanco宣布Trucan™ Ultra Lyme-L4获美国农业部批准，成为首款且唯一一款用于犬类的莱姆病与钩端螺旋体病0.5毫升联合疫苗</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElanco宣布Trucan™ Ultra Lyme-L4获美国农业部批准，成为首款且唯一一款用于犬类的莱姆病与钩端螺旋体病0.5毫升联合疫苗\n</h2>\n\n<h4 class=\"meta\">\n\n2026-06-15 20:47 北京时间&nbsp;&nbsp;&nbsp;<strong>美股速递</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Elanco Animal Health Inc宣布，其研发的Trucan™ Ultra Lyme-L4疫苗已获得美国农业部（USDA）的正式批准。该产品是全球首个且目前唯一一款针对犬类莱姆病和钩端螺旋体病的0.5毫升联合疫苗，标志着动物疫苗领域的一项重要突破。这一进展有望为宠物犬提供更便捷、高效的疾病防护方案。</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1941712348.USD","symbol_name":"ALLIANZ PET AND ANIMAL WELLBEING \"AT\" (USD) ACC","start_time":0,"source_url":"","article_id":"1140079176","we_media_id":"1004306016","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1140079176","pubTimestamp":1781527637,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"美股速递","introduction":"全球快讯第一时间播报","home_visible":1,"id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Elanco Animal Health Inc宣布，其研发的Trucan™ Ultra Lyme-L4疫苗已获得美国农业部（USDA）的正式批准。该产品是全球首个且目前唯一一款针对犬类莱姆病和钩端螺旋体病的0.5毫升联合疫苗，标志着动物疫苗领域的一项重要突破。这一进展有望为宠物犬提供更便捷、高效的疾病防护方案。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU1941712348.USD":"ALLIANZ PET AND ANIMAL WELLBEING \"AT\" (USD) ACC","LU1941712264.USD":"ALLIANZ PET AND ANIMAL WELLBEING \"A\" (USD) INC","ELAN":"Elanco Animal Health Inc","BK4561":"索罗斯持仓","BK4007":"制药"},"translate_title":"Elanco Announces Trucan ™ Ultra Lyme-L4 Approved by the U.S. Department of Agriculture as the First and Only Lyme Disease and Leptospirosis 0.5ml Combination Vaccine for Dogs","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELAN":1},"content_text":"Elanco Animal Health Inc宣布，其研发的Trucan™ Ultra Lyme-L4疫苗已获得美国农业部（USDA）的正式批准。该产品是全球首个且目前唯一一款针对犬类莱姆病和钩端螺旋体病的0.5毫升联合疫苗，标志着动物疫苗领域的一项重要突破。这一进展有望为宠物犬提供更便捷、高效的疾病防护方案。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1140079176","isCrawlerRequest":true}